𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers

✍ Scribed by P. Rousso; T. Buclin; J. Nussberger; F. Brunner-Ferber; H. R. Brunner; J. Biollaz

Publisher
Springer
Year
2000
Tongue
English
Weight
112 KB
Volume
55
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of the angiotensin conv
Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril·HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration
✍ Dr. Günther Kaiser; Roland Ackermann; Sylvia Brechbühler; Walter Dieterle 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 577 KB

The pharmacokinetics of the new angiotensin converting enzyme (ACE) inhibitor benazeprikHC1 were evaluated in healthy male volunteers. The single dose kinetics were established from data of 62 subjects receiving an oral 10 mg dose of the drug. The steady state kinetics were investigated in 15 subjec

The absence of a pharmacokinetic interac
The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers
✍ A. Sioufi; F. Pommier; N. Gauducheau; J. Godbillon; L. Choi; V. John 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

Potential effects of the coadministration of single doses of aspirin (325mg) and of benazepril hydrochloride (20 mg) on the pharmacokinetics and the metabolism of these two drugs were evaluated in 12 healthy subjects. Plasma concentration profiles of benazepril, its active metabolite benazeprilat, a